Literature DB >> 21396595

Ex vivo expansion of mesenchymal stromal cells.

Maria Ester Bernardo1, Angela Maria Cometa, Daria Pagliara, Luciana Vinti, Francesca Rossi, Rosaria Cristantielli, Giuseppe Palumbo, Franco Locatelli.   

Abstract

Mesenchymal stromal cells (MSCs) are adult multipotent cells that can be isolated from several human tissues. MSCs represent a novel and attractive tool in strategies of cellular therapy. For in vivo use, MSCs have to be ex vivo expanded in order to reach the numbers suitable for their clinical application. Despite being efficacious, the use of fetal calf serum for MSC ex vivo expansion for clinical purposes raises concerns related to immunization and transmission of zoonoses; the standardization of expansion methods, possibly devoid of animal components, such as those based on platelet lysate, are discussed in this paper. Moreover, this review focuses on the search of novel markers for the prospective identification/isolation of MSCs and on the potential risks connected with ex vivo expansion of MSCs, in particular that of their malignant transformation. Available tests to study the genetic stability of ex vivo expanded MSCs are also analyzed.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396595     DOI: 10.1016/j.beha.2010.11.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  42 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

3.  Osteogenic differentiation of 3D cultured mesenchymal stem cells induced by bioactive peptides.

Authors:  Vera Lukasova; Matej Buzgo; Vera Sovkova; Jana Dankova; Michala Rampichova; Evzen Amler
Journal:  Cell Prolif       Date:  2017-08       Impact factor: 6.831

4.  Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Authors:  Elena Veronesi; Alba Murgia; Anna Caselli; Giulia Grisendi; Maria Serena Piccinno; Valeria Rasini; Rosaria Giordano; Tiziana Montemurro; Philippe Bourin; Luc Sensebé; Markus T Rojewski; Hubert Schrezenmeier; Pierre Layrolle; Maria Pau Ginebra; Carmen Bunu Panaitescu; Enrique Gómez-Barrena; Fabio Catani; Paolo Paolucci; Jorge S Burns; Massimo Dominici
Journal:  Tissue Eng Part C Methods       Date:  2013-08-20       Impact factor: 3.056

Review 5.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

6.  Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate.

Authors:  Camilla Siciliano; Mohsen Ibrahim; Gaia Scafetta; Chiara Napoletano; Giorgio Mangino; Luca Pierelli; Giacomo Frati; Elena De Falco
Journal:  Cytotechnology       Date:  2013-12-04       Impact factor: 2.058

7.  Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.

Authors:  Antoinette Flemming; Katharina Schallmoser; Dirk Strunk; Meaghan Stolk; Hans-Dieter Volk; Martina Seifert
Journal:  J Clin Immunol       Date:  2011-09-02       Impact factor: 8.317

Review 8.  Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.

Authors:  Settimio Pacelli; Sayantani Basu; Jonathan Whitlow; Aparna Chakravarti; Francisca Acosta; Arushi Varshney; Saman Modaresi; Cory Berkland; Arghya Paul
Journal:  Adv Drug Deliv Rev       Date:  2017-07-19       Impact factor: 15.470

9.  Mesenchymal stromal cells for steroid-refractory acute GvHD.

Authors:  C Fernández-Maqueda; R Gonzalo-Daganzo; C Regidor; T Martín-Donaire; R Sánchez; J L Bueno; G Bautista; A De Liglesia; Y Gutiérrez; M García-Berciano; R Forés; A Royuela; M N Fernández; R F Duarte; J R Cabrera-Marín
Journal:  Bone Marrow Transplant       Date:  2017-08-07       Impact factor: 5.483

10.  In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow.

Authors:  Sabine Wislet-Gendebien; Christophe Poulet; Virginie Neirinckx; Benoit Hennuy; James T Swingland; Emerence Laudet; Lukas Sommer; Olga Shakova; Vincent Bours; Bernard Rogister
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.